Variation in genomic landscape of clear cell renal cell carcinoma across Europe.
about
Genomics of Cancer and a New Era for Cancer PreventionCancer prevention as part of precision medicine: 'plenty to be done'Balkan endemic nephropathy: an update on its aetiologyAristolochic acid exposure in Romania and implications for renal cell carcinomaBase changes in tumour DNA have the power to reveal the causes and evolution of cancer.Causality in cancer research: a journey through models in molecular epidemiology and their philosophical interpretation.Genome-wide association study identifies multiple risk loci for renal cell carcinoma.A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data.Mutation signatures implicate aristolochic acid in bladder cancer developmentNew Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid.Omeprazole Alleviates Aristolochia manshuriensis Kom-Induced Acute Nephrotoxicity.Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysisLow-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid.Independent Tumor Origin in Two Cases of Synchronous Bilateral Clear Cell Renal Cell Carcinoma.Sulfotransferase-1A1-dependent bioactivation of aristolochic acid I and N-hydroxyaristolactam I in human cells.Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma.Tumour and patient factors in renal cell carcinoma-towards personalized therapy.New advances in genitourinary cancer: evidence gathered in 2014.Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients.Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma.International cancer seminars: a focus on kidney cancer.Molecular profiling of renal cell carcinoma: building a bridge toward clinical impact.Precision medicine from the renal cancer genome.Aristolochic Acid in the Etiology of Renal Cell Carcinoma.GHSR hypermethylation: a promising pan-cancer marker.Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.Intra-tumour molecular heterogeneity of clear cell renal cell carcinoma reveals the diversity of the response to targeted therapies using patient-derived xenograft models.Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.*K-means and cluster models for cancer signatures.Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy.DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer.Decreased TGFBR3/betaglycan expression enhances the metastatic abilities of renal cell carcinoma cells through TGF-β-dependent and -independent mechanisms.Large-scale genome-wide screening of circulating microRNAs in clear cell renal cell carcinoma reveals specific signatures in late-stage disease.Consequences of VHL Loss on Global DNA Methylome.Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.Generation of autochthonous mouse models of clear cell renal cell carcinoma: mouse models of renal cell carcinoma.Global characterization of copy number variants in epilepsy patients from whole genome sequencing.Hypoxic marker CA IX and adhesion mediator β-catenin are downregulated by lymphocytic choriomeningitis virus persistent infection.
P2860
Q26779113-1EF900EC-24BC-49AB-8FBC-8B74D3C96AA7Q26995183-3F2A352F-DAEB-4D1C-AAFA-D62FAD1DBA0BQ28079308-609DE98D-AC4D-41C4-841C-05BEBD346360Q28602446-6FB35DBF-EBDD-4D4C-A9DA-C7505BA0A559Q30249783-1B9C1052-5E46-4E10-BE75-A1C2759B9980Q30402873-3E0CE09B-982A-4068-845E-FEB4B9582CA2Q33804470-F959F72F-AC07-450D-AF43-3843A1713015Q33869005-3A151818-3F14-44C1-91EF-EE4DD407C2ACQ35646186-A88EF567-0207-4F58-9333-07434F2BC82AQ36041371-680F9BC0-73EF-40F2-888A-85F74877AA5FQ36157755-B09C9E48-AD3C-481A-974D-9318ADB0093DQ36367103-24C7F6F5-D68D-4D2D-A603-CA48BC4254E6Q36725046-D0020BB7-136B-46D2-B8C9-5ADD4B524672Q37072963-9F33291E-5645-4B09-94D2-DA6AA606C79DQ37074055-A9454CB4-2B72-4C34-9534-BD42D7DA5231Q37717383-A2373DF2-5B94-4607-AA66-A34CBD8B2B4AQ38418649-F88E5E4C-ABC4-43AC-B11F-9A7D4CE5669CQ38557894-CC7D2533-BD3B-4952-97A0-8AE8002DEAF3Q38620814-0664F073-4A03-4EAA-B27C-315AD1154219Q38655126-C4CE32AB-54D5-42D1-B87E-70943559B5C1Q38873586-76DB3AA6-A6D2-43BE-A891-10F139CFAD8FQ38910995-C5DEA4AC-A7CF-4DC4-AF87-BC781ACF4860Q38970282-FAFA64DF-2B4C-4431-AAB7-C9163991B76EQ39459925-91731201-B9C2-45C1-AEEA-59E0D273B7F4Q40216663-98BEF32F-9F5D-4A16-97B4-B18126B1FB3EQ40243097-8CB554C6-EF00-4EE3-A1D6-79122829B179Q41472778-1A36F1AE-2393-49B9-90BD-55F8B402833FQ41574276-CC250A20-C76E-4D6B-B597-8ECA4B382E19Q42265689-74BA4FC9-E5DF-4D72-B360-31C9C68F713AQ45901125-D8EE579A-79EF-4F7C-9132-1839CB4F28CCQ47096788-27D8EC00-77D3-4833-AD38-84142EBC6BEFQ48120175-A7CA4475-1E77-4E86-B771-283EBFEA7C4AQ48238662-45D02CA5-41E4-4617-9F2F-09EED0E30305Q49789775-E6245DFB-7989-48BD-A586-AE5D4E40CCBCQ52321029-EF005FDF-DF48-4588-B9FC-7451938EB086Q52321032-EB98A250-9CCE-485D-BB48-5D3F8D312E90Q52321041-2A1EFA05-5E25-4D85-BB57-3E30D722A0AFQ52590924-48F142D6-B16A-4B7D-831B-79A5C9E8A645Q52591846-AC351034-19E3-4B86-B604-D8276BAC836DQ52645855-F4EFAC66-0B31-4D9A-A962-B8983E7AEB25
P2860
Variation in genomic landscape of clear cell renal cell carcinoma across Europe.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Variation in genomic landscape of clear cell renal cell carcinoma across Europe.
@en
Variation in genomic landscape of clear cell renal cell carcinoma across Europe.
@en-gb
Variation in genomic landscape of clear cell renal cell carcinoma across Europe.
@nl
type
label
Variation in genomic landscape of clear cell renal cell carcinoma across Europe.
@en
Variation in genomic landscape of clear cell renal cell carcinoma across Europe.
@en-gb
Variation in genomic landscape of clear cell renal cell carcinoma across Europe.
@nl
prefLabel
Variation in genomic landscape of clear cell renal cell carcinoma across Europe.
@en
Variation in genomic landscape of clear cell renal cell carcinoma across Europe.
@en-gb
Variation in genomic landscape of clear cell renal cell carcinoma across Europe.
@nl
P2093
P2860
P50
P356
P1476
Variation in genomic landscape of clear cell renal cell carcinoma across Europe.
@en
P2093
Alexander Mazur
Alexandre How-Kit
Andris Zarins
Anne Cambon-Thomsen
Antoine Daunay
Anush Moukeria
Artem Artemov
Christine Carreira
Doris Lechner
Edgars Celms
P2860
P2888
P356
10.1038/NCOMMS6135
P407
P50
P577
2014-10-29T00:00:00Z